Basket cover image
15 handpicked stocks

Addictive Products

These companies have mastered the art of creating products customers can't live without. Our analysts have carefully selected businesses with loyal followings and consistent revenue streams, giving you access to brands that keep customers coming back for more.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at जून 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

DKNG

DraftKings

DKNG

Current price

$45.02

As a dominant force in online sports betting and daily fantasy sports, its platform is designed for constant user interaction.

MGM

MGM Resorts International

MGM

Current price

$36.71

This global casino and resort operator provides a vast ecosystem of gambling and entertainment experiences that encourage repeat visits.

PENN

Penn Entertainment Inc

PENN

Current price

$18.52

It operates a diversified portfolio of casinos and online gaming brands, including ESPN BET, capturing a wide audience of engaged users.

About This Group of Stocks

1

Our Expert Thinking

We've focused on companies that create powerful psychological feedback loops. These businesses specialize in products that become part of daily routines, offering intermittent rewards that keep users engaged and coming back. This habit-forming approach leads to predictable, recurring revenue streams.

2

What You Need to Know

This collection primarily features gaming and entertainment companies that excel at customer retention. From casino operators and online sportsbooks to gaming technology suppliers, these businesses have perfected the science of high-frequency engagement and brand loyalty.

3

Why These Stocks

Each company was selected for its market leadership and proven ability to build a loyal, recurring customer base. Many are benefiting from the ongoing legalization of online sports betting and iGaming across new markets, creating significant growth opportunities in this specialized consumer sector.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+70.12%

Group Performance Snapshot

70.12%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 70.12% over the next year.

10 of 12

Stocks Rated Buy by Analysts

10 of 12 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🎲

Betting on Habits, Not Luck

These companies have cracked the code on customer loyalty. By creating products that trigger dopamine responses and become part of daily routines, they've built businesses with incredibly sticky revenue streams.

📱

The Digital Gaming Gold Rush

As more states and countries legalize online sports betting and iGaming, these companies are positioned at the forefront of a massive market expansion. Early movers are capturing valuable market share in this rapidly growing space.

🔄

The Power of Repeat Business

Unlike companies that need to constantly find new customers, these businesses excel at keeping existing ones. Their products create powerful feedback loops that encourage regular engagement and spending.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Orphan Drug Moats: Leaders In Rare Disease

Orphan Drug Moats: Leaders In Rare Disease

The FDA's rejection of PTC Therapeutics' drug for a rare genetic disorder has delayed a new treatment option and created a significant setback for the company. This regulatory decision strengthens the competitive position of companies with already-approved therapies for rare diseases, highlighting the value of a proven drug portfolio.

View stocks
Nvidia's China Chip Pivot

Nvidia's China Chip Pivot

Nvidia is developing a new, compliant AI chip for China, aiming to recapture market share lost to U.S. export controls. This strategic pivot creates a ripple effect, potentially benefiting the entire semiconductor supply chain that supports the production and deployment of this advanced hardware.

View stocks
Navigating The Autonomous Driving Shakeout

Navigating The Autonomous Driving Shakeout

A class-action lawsuit against Tesla regarding its Full Self-Driving claims puts the company's marketing and technology under intense scrutiny. This legal challenge could boost demand for competing autonomous driving technologies, creating opportunities for companies that supply advanced sensors and software.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.